pyridostigmine
Selected indexed studies
- Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review. (ANZ J Surg, 2023) [PMID:37132128]
- Pyridostigmine for the Management of Neurogenic Orthostatic Hypotension: A Systemic Review. (J Geriatr Psychiatry Neurol, 2025) [PMID:39043171]
- ALSUntangled #81: Pyridostigmine (mestinon(®)). (Amyotroph Lateral Scler Frontotemporal Degener, 2026) [PMID:41196032]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review. (2023) pubmed
- Pyridostigmine for the Management of Neurogenic Orthostatic Hypotension: A Systemic Review. (2025) pubmed
- ALSUntangled #81: Pyridostigmine (mestinon(®)). (2026) pubmed
- Pyridostigmine in the treatment of orthostatic intolerance. (2007) pubmed
- Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials. (2020) pubmed
- Pyridostigmine-induced microcephaly. (2000) pubmed
- Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis. (2018) pubmed
- The pharmacokinetics of pyridostigmine. (1976) pubmed
- Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry. (2022) pubmed
- Pyridostigmine-induced microcephaly. (2001) pubmed